207 results
Page 6 of 11
8-K
EX-99.1
cbo5y01fqx9wlyxzut70
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
cqbeapitqn
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
w78sauf4
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
8bfp4ihevs6v3xm30z3k
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
2glgh7
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
et4ai544k1aemfqw9
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
wo9jx3mf034wr4z0h7g1
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
e79q0b09z6y
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
3zsr5 h8u25jp
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
nq5f9ey
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
jtq4yo8e6kvzzpj578n
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
rkc4kuyet9ws
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
zve t1eck
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
tme7yn9p
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
7b92de7n
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
S-8
lfsht65q578iyl2gb
9 Aug 19
Registration of securities for employees
5:12pm